Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | PRKAA2 | P54646 | 4/20 | 0.39 |
| ▸ | USP30 | Q70CQ3 | 4/20 | 0.38 |
| ▸ | UCHL1 | P09936 | 3/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.37 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.37 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.37 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | IDH1 | O75874 | 1/20 | 0.35 |
| ▸ | HRH2 | P25021 | 2/20 | 0.34 |
| ▸ | HRH1 | P35367 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3662714 | 0.92 | USP30 (0.42) | THRBPRKAA2USP30UCHL1DPP4 | |
| SCHEMBL3664571 | 0.89 | USP30 (0.39) | USP30UCHL1GPR119F10 | |
| SCHEMBL648681 | 0.89 | THRB (0.54) | THRBPRKAA2USP30UCHL1DPP4 | |
| SCHEMBL3661362 | 0.85 | USP30 (0.40) | THRBUSP30UCHL1 | |
| SCHEMBL648608 | 0.83 | THRB (0.59) | THRBPRKAA2USP30UCHL1DPP4 | |
| SCHEMBL4401696 | 0.80 | THRB (0.54) | THRBPRKAA2GPR119CYP3A4 | |
| SCHEMBL647468 | 0.80 | THRB (0.51) | THRBPRKAA2USP30UCHL1CYP3A4 | |
| SCHEMBL4405690 | 0.78 | SCN8A (0.43) | THRBPRKAA2CYP3A4 | |
| SCHEMBL650729 | 0.77 | LIPE (0.43) | THRBPRKAA2USP30UCHL1 | |
| SCHEMBL3667019 | 0.77 | PRKAA2 (0.49) | PRKAA2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2231600-A1 | CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS | Rigel Pharmaceuticals, Inc. (US) | 2010-09-29 | — | — | EP | claimed |
| WO-2009065131-A1 | CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS | RIGEL PHARMACEUTICALS, INC. (US) | 2009-05-22 | — | — | WO | claimed |